Finally, it might be hypothesized that AD co‐pathology, as measured by phosphorylated tau (p‐tau)217 or amyloid beta (Aβ)42/Aβ40 ratio,26, 27 might affect survival rate in FTLD. The gene discussed is MAPT; the disease is Alzheimer disease.